170503 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Molecules with a "CD"-designation not provided for elsewhere in
SYSTEM, METHOD, AND ARTICLE FOR DETECTING ABNORMAL CELLS USING MULTI-DIMENSIONAL ANALYSIS
#2CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#3Methods for Evaluating Angiogenesis
#4CONTROL CELL POPULATIONS FOR DETECTION OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
#5PRODUCTION AND USE OF NATURAL KILLER (NK) CELL-DERIVED EXTRACELLULAR VESICLES FOR TREATMENT OF CANCER AND INFECTIOUS DISEASE
#6ANTI-TLR9 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#7METHODS FOR SELECTING CULTURED CORNEAL ENDOTHELIAL CELLS
#8SMAGP FUSION MOLECULES AND METHODS OF USE THEREOF
#9ENDOGLIN ANTIBODIES AND USES THEREOF
#10BIOMARKER PANEL, MICROFLUIDIC DEVICE AND DETECTION KIT FOR CAPTURING CIRCULATING TUMOR CELLS
#11ANTI-CD157 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#12CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#13USE OF EXTRACELLULAR VESICLES AND MICRONUCLEI OF CIRCULATING STROMAL CELLS AS PAN-CANCER BIOMARKERS FOR PREDICTING CLINICAL OUTCOMES
#14ADULT STEM CELL COMPOSITIONS AND METHODS OF IDENTIFICATION AND ISOLATION
#15METHOD FOR MEASURING MINERALOCORTICOID RECEPTOR ACTIVITY
#16METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR
#17ANTI-L1-CAM ANTIBODIES AND THEIR USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#18METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#19COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#20COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#21BIOMARKERS, DIAGNOSTIC METHODS, TREATMENTS, AND THERAPEUTICS FOR AUTOIMMUNE DISORDERS AND DISEASES
#22COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#23PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#24A METHOD FOR PREDICTING THE RESPONSE OF METASTASES TO IMMUNOTHERAPY IN A METASTATIC COLORECTAL CANCER PATIENT
#25METHODS AND SYSTEMS FOR DEVELOPING MEDIA FOR EXTRACELLULAR VESICLE PRODUCTION
#26ANTI-CD94 ANTIBODY AND USE THEREOF
#27METHODS AND PRODUCTS FOR DETERMINING RESPONSIVENESS TO ANTI-PD1 IMMUNE CHECKPOINT INHIBITOR IMMUNOTHERAPY
#28BIOMARKERS FOR FIBROSIS TREATMENT USING ANTI-CLAUDIN-1 ANTIBODIES
#29BIOMARKERS FOR DIAGNOSING EQUINE ASTHMA
#30BIOMARKERS FOR ALLERGEN IMMUNOTHERAPY
#31ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE
#32COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#33COMPOSITIONS AND METHODS FOR PLASMAPHERESIS
#34METHODS AND AGENTS FOR DETERMINING PATIENT STATUS
#35NANOBODY AND NANOBODY-DRUG CONJUGATE TARGETING CD73, METHOD FOR PREPARING SAME, AND USE THEREOF
#36ANTI-CD1A ANTIBODIES
#37ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF
#38METHODS FOR DETECTING A CANCER
#39CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS
#40IL-10-Producing CD4+ T Cells and Uses Thereof
#41BIOMARKERS OF LYSOSOMAL STORAGE DISEASE
#42DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#43BIOMARKERS AND METHODS FOR TREATING NSCLC
#44METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#45COMBINATION THERAPY FOR TREATMENT OF CANCER COMPRISING ANTI-PD-L1 AND ANTI-CD73 ANTIBODIES
#46MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS
#47MULTI-DOMAIN MOLECULES
#48ENIGMA AND CDH18 AS COMPANION DIAGNOSTICS FOR CDK4 INHIBITORS
#49CHROMOGENIC MULTIPLEXING METHODS AND SYSTEMS FOR IDENTIFYING A CANCER OF UNKNOWN PRIMARY ORIGIN
#50MICROIMPRINTING OF ANTIBODIES AND BIOMOLECULES FOR CELL PHENOTYPING AND ACTIVATION
#51METHOD FOR MEASURING CELLULAR UPTAKE OF MOLECULES
#52LIQUID BIOPSY FOR DIAGNOSIS OF EARLY OSTEOARTHRITIS
#53METHODS FOR PREDICTING TREATMENT RESPONSE IN PSORIASIS
#54THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER
#55METHOD FOR CLASSIFYING CELLS
#56BLADDER CANCER BIOMARKERS AND METHODS OF USE
#57MULTISPECIFIC ANTIBODIES TARGETING CD79B/CD3 AND THE USES THEREOF
#58METHOD FOR MEASURING ACTIVITY OR CONCENTRATION OF ALKALINE PHOSPHATASE CONTAINED IN EXTRACELLULAR VESICLE IN SAMPLE, POLYPEPTIDE MOLECULE, METHOD FOR PRODUCING THE SAME, AND CALIBRATOR
#59METHODS AND COMPOSITIONS FOR PROGNOSIS AND TREATMENT OF DILATED CARDIOMYOPATHY AND HEART FAILURE
#60ASSAYS AND METHODS OF USE OF THOSE ASSAYS IN THE CARE AND DIAGNOSIS OF STROKE PATIENTS
#61Combination Of Proteotypic Peptides For The Detection Of Proteins In The Pd-L1 Axis
#62CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
#63METHOD OF MEASURING LEVEL OF IMMUNE SUPPRESSION
#64MONOCLONAL ANTIBODY USED FOR DIAGNOSIS AND EARLY ONSET OF PROSTATE CANCER
#65CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
#66CD38-BINDING AGENTS AND USES THEREOF
#67CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
#68THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER
#69TEST SYSTEM FOR OBTAINING A BLOOD COUNT SUITABLE FOR HOME USE AND TELEMEDICINE
#70ANTI-CD161 ANTIBODIES AND USES THEREOF
#71ANTI-CD39 NANOBODY AND USES THEREOF
#72METHOD AND KIT FOR REDUCING INTERFERENCES IN IMMUNOASSAYS
#73METHOD FOR PREDICTING PATIENT RESPONSE TO IMMUNOTHERAPY
#74ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
#75SENESCENT CELL SURFACE MARKERS
#76CEACAM1 BASED POINT-OF-CARE CANCER DIAGNOSTIC
#77CD161 BINDING PROTEINS AND RELATED METHODS
#78TARGETING NEUROPILIN 2 (NRP2) IN LETHAL PROSTATE CANCER
#79SYSTEM AND METHOD FOR QUANTIFICATION OF DIGITIZED PATHOLOGY SLIDES
#80USE OF CD38+HLA-DR+CD8+ T CELL IN EARLY DIAGNOSIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
#81BIOCHEMICAL ASSAYS FOR THERAPEUTIC PROTEINS
#82Methods of Identifying and Treating Progressive Colorectal Cancer
#83CD206 Targeted Peptide Conjugates and Methods of Using the Same
#84Serum Immune-Based Biomarkers for Use in ALS Therapy
#85IN VITRO QUALITY SCREENING OF HUMAN CORNEAL STROMAL STEM CELLS FOR CELL-BASED THERAPY OF CORNEAL SCARRING
#86GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR-BASED TREATMENTS FOR NEURODEGENERATIVE OR NEUROLOGICAL DISEASES OR DISORDERS
#87METHOD FOR DIAGNOSING ENDOMETRIOSIS AND FOR CLASSIFYING THE STAGE OF ENDOMETRIOSIS
#88METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING TUMOR CELL MIMICS
#89METHODS FOR CHARACTERIZATION OF CIRCULATING TUMOR CELLS
#90Anti-CD161 antibodies and uses thereof
#91A BIOMARKER INDICATING THE THERAPEUTIC EFFICACY OF EXTRACELLULAR VESICLE (EV)- PREPARATIONS
#92INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION
#93METHODS AND SYSTEMS FOR PREDICTING RESPONSE TO PD-1 AXIS DIRECTED THERAPEUTICS IN COLORECTAL TUMORS WITH DEFICIENT MISMATCH REPAIR
#94IMPROVED EXOSOME PROFILING FOR THERAPY AND DIAGNOSIS
#95Aptamer-Based Fluorescence Polarization Detection Method for Extracellular Vesicles and Its Application
#96BIOMARKERS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE
#97CD34 STEM CELL MIMICS
#98EPIGENTIC REGULATION AND CO-TARGETING APPROACHES OF PSMA IN PROSTRATE CANCER
#99USE OF BMMF1 REP PROTEIN AS DIAGNOSTIC MARKER FOR LUNG CANCER
#100STATISTICAL ANALYSIS OF THE OVARIAN TUMOR IMMUNE MICROENVIRONMENT USING MULTIPLEX IMMUNOFLUORESCENCE
#101CRITICALLY-LOCKED MECHANICAL METAMATERIAL FOR HYPER-RESPONSIVE MOLECULAR PROFILING
#102ANTIBODY MOLECULES TO PD-1 AND USES THEREOF
#103GLX-DERIVED MOLECULE DETECTION
#104Use of PD-L1 Low Expression Status to Select Subjects for Cancer Immunotherapy
#105METHOD FOR DETERMINING BASOPHIL ACTIVATION IN A SAMPLE
#106KIDNEY-ON-A-CHIP COMPRISING RENAL TUBULE CULTURE PART AND INTERSTITIUM CULTURE PART
#107ANTIBODIES AND USES THEREOF
#108SANDWICH IMMUNOASSAY DEVICES USING ANTIBODIES SPECIFIC TO THE EXOSOMES CONTAINING TARGET ANALYTES
#109METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
#110METHODS FOR PREDICTING RESPONSE TO AN IMMUNOTHERAPEUTIC TREATMENT IN A PATIENT WITH A CANCER
#111COMPOSITIONS AND METHODS FOR DETECTING CADHERIN-17 PROTEIN
#112Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#1133D BIOASSAYS TO MEASURE ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY
#114METHODS OF ASSAYING MICRO-OBJECTS IN A MICROFLUIDIC DEVICE
#115METHODS FOR DETECTING DYSFUNCTIONAL NK CELLS IN LEUKEMIA PATIENTS
#116ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
#117METHODS, COMPOSITIONS AND SYSTEMS FOR USING POOLED DONOR SAMPLES FOR LABORATORY TESTING
#118TARGETING IMMUNE INFILTRATION TO THE CENTRAL NERVOUS SYSTEM (CNS)
#119PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY
#120ANTI-CD39 Antibody, Preparation Method Therefor And Use Thereof
#121PEPTIDE-BINDING HYBRID LIPOSOME EXOSOME, PEPTIDE-BINDING EXOSOME, COMPOSITION CONTAINING SAME, AND METHOD OF FORMING SAME
#122ANTI-HUMAN CD10 ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS TO DIAGNOSE CANCER
#123METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER
#124METHOD FOR DETECTING AND ISOLATING CELL POPULATION CO-EXPRESSING CD45 AND EPCAM AND USE THEREOF
#125PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#126ANTIGEN-BINDING POLYPEPTIDES AGAINST CD73
#127CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
#128IVALTINOSTAT COMBINATION THERAPY FOR TREATING PANCREATIC CANCER
#129IgE+ PLASMABLASTS AS A PREDICTIVE BIOMARKER OF ALLERGY
#130Compositions and methods for plasmapheresis
#131CORNEAL ENDOTHELIAL CELL MARKER
#132Method for Magnetically Sorting Biological Objects
#133SYSTEMS AND METHODS FOR CYTOCAPTURE OF IMMUNE CELLS TO DETECT INTERNAL INFECTIONS
#134ANTIGEN CD111 AS A NEW SPECIFIC DIAGNOSTIC AND THERAPEUTIC MARKER FOR POLYMORPHONUCLEAR MYELOID-DERIVED SUPPRESSOR CELLS (PMN-MDSCS)
#135EARLY DIAGNOSIS OF INFECTIONS
#136BIOMARKERS FOR PARKINSON'S DISEASE
#137DIAGNOSIS AND TREATMENT OF ECTOPIC ENDOMETRIOSIS
#138ON-BOARD CONJUGATION
#139Therapeutic Anti-CD9 Antibody
#140ANTIGEN-BINDING POLYPEPTIDES AGAINST CD39
#141A METHOD OF DETECTING A POPULATION OF MACROPHAGES
#142ANTI-CD79BxCD3 BISPECIFIC ANTIBODY AND USE THEREOF
#143SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#144METHOD FOR MEASURING EXTRACELLULAR VESICLES, METHOD FOR ACQUIRING INFORMATION ON NEURODEGENERATION, METHOD FOR ISOLATING EXTRACELLULAR VESICLES, AND REAGENT KIT
#145METHODS OF ISOLATING A BIOLOGICAL ENTITY
#146METHODS OF ISOLATING OF TUMOR INFILTRATING LYMPHOCYTES AND USE THEREOF
#147NATURAL KILLER CELL EFFICACY PREDICTION METHOD AND COMPUTING DEVICE
#148IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT
#149SELECTION OF PATIENTS FOR COMBINATION THERAPY
#150Compositions and methods for plasmapheresis
#151DETECTION OF ACUTE MYELOID LEUKAEMIA
#152Anti-CD161 antibodies and uses thereof
#153METHOD OF PREDICTING RESPONSE TO IMMUNOTHERAPY
#154ANTI-CD33 ANTIBODIES AND USES THEREOF
#155ANTI-CD38 SINGLE DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT
#156ANTI-uPAR ANTIBODIES AND USES THEREOF
#157SANDWICH IMMUNOASSAY DEVICES USING ANTIBODIES SPECIFIC TO THE EXOSOMES CONTAINING TARGET ANALYTES
#158NOVEL BIOLOGICAL MARKERS IN THE DIAGNOSIS OF ENDOMETRIOSIS
#159PREDICTION OF STEM CELL THERAPY RESPONSIVENESS BY QUANTIFICATION OF PRE-EXISTING B REGULATORY CELLS
#160MOLECULAR ANALYSIS OF EXTRACELLULAR VESICLES (EVs) FOR THE PREDICTION AND MONITORING OF DRUG RESISTANCE IN CANCER
#161PRESEPSIN MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#162COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#163METHOD FOR MANUFACTURING A PATIENT SPECIFIC CELL POPULATION USING A MULTIFUNCTIONAL SELF-CONTAINED APPARATUS AND TUBING SET
#164BATCH RELEASE ASSAY FOR PHARMACEUTICAL PRODUCTS RELATING TO T CELL THERAPIES
#165THERAPEUTIC ANTIBODIES
#166MARKERS OF AUTOIMMUNE DISEASES
#167ANTIBODY AGAINST PANCREATIC CANCER STEM CELLS
#168Method and Apparatus for Magnetically Sorting Rare Cells
#169COMPOSITION FOR DIFFERENTIAL DIAGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
#170ANTI-HUMAN CD73 ANTIBODY AND USE THEREOF
#171HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS
#172COMPOSITIONS AND METHODS FOR SELECTIVE CAPTURE, PURIFICATION, RELEASE AND ISOLATION OF SINGLE CELLS
#173Novel Biomarker
#174COLLECTION AND USES OF TISSUE RESIDENT INTERSTITIAL EXTRACELLULAR VESICLES
#175LUNG-CANCER SPECIFIC T CELL DYSFUNCTION
#176NON-HUMAN ANIMALS HAVING A HUMANIZED CLUSTER OF DIFFERENTIATION 47 GENE
#177METHODS OF ASSESSING CELL PRODUCTS
#178SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR)
#179ANTI-CD20 ANTIBODY AND USES THEREOF
#180ANTI-CD20 ANTIBODY AND USES THEREOF
#181ANTI-UPAR ANTIBODIES AND USES THEREOF
#182METHODS, ASSAYS AND COMPOSITIONS FOR MEASURING BRAIN DAMAGE OR HARM DURING SURGERY
#183METHODS AND MATERIALS FOR ASSESSING AND TREATING CANCER
#184BIOMARKER FOR PREDICTING RESPONSIVENESS TO ANTICANCER AGENT AND USE THEREOF
#185BIOSENSOR AND METHOD FOR DETERMINATION OF VIRUSES IN CORONAVIRUS FAMILY
#186MARKERS OF ACUTE MYELOID LEUKEMIA STEM CELLS
#187BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#188KIDNEY FUNCTION BIOMARKERS
#189BIOMARKER FOR DETERMINING FERTILITY, AND DETERMINING METHOD USING SAME
#190METHODS OF SELECTIVELY TARGETING CD6 HIGH CELLS AND DECREASING ACTIVITY OF TEFF CELLS
#191NOVEL ANTI-CD24 ANTIBODIES
#192Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
#193SYSTEM, METHOD, AND ARTICLE FOR DETECTING ABNORMAL CELLS USING MULTI-DIMENSIONAL ANALYSIS
#194DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#195DETECTION OF DEBRIS IN RECIRCULATING PHAGOCYTES
#196METHOD OF ASSISTING BREAST CANCER DIAGNOSIS AND TEST KIT FOR BREAST CANCER
#197B CELL MONITORING REAGENT PANEL AND REAGENT KIT FOR ANALYZING B CELL SUBSETS IN ANTI-CD20 TREATED AUTOIMMUNE PATIENTS
#198Time Dependent Response of Basophils to Allergens
#199METHODS FOR THE DIAGNOSIS AND THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE
#200ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)
#201CELL PREPARATION, USE OF PROTEIN IN CHARACTERIZING HEMATOPOIETIC STEM CELLS, AND METHOD FOR DETERMINING HEMATOPOIETIC STEM CELLS
#202METHODS FOR DIAGNOSIS AND MONITORING OF TOXIC EPIDERMAL NECROLYSIS
#203ANTI-CD20 ANTIBODY AND USES THEREOF
#204Reagent composition for detection of non-hematopoietic tumor and use thereof
#205ANTI-PD-L1 ANTIBODY AND USE THEREOF
#206Method for Determining Prognosis of Cancer
#207URINARY GLYCOPROTEINS FOR THE EARLY DETECTION AND TREATMENT OF AGGRESSIVE PROSTATE CANCER
#208BIOMARKERS FOR PREDICTING OVERALL SURVIVAL IN RECORRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA
#209Methods and Devices For Complexing Target Entities
#210METHODS AND COMPOSITIONS FOR IN SITU IMMUNE PROFILING OF HEART TRANSPLANT BIOPSIES
#211PROGNOSTIC VALUE OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HAVING STABLE DISEASE
#212METHODS FOR TREATING GLIOBLASTOMA
#213HIGHLY SENSITIVE PLATFORM TO CHARACTERIZE EXTRACELLULAR VESICULAR BIOMARKERS FOR CANCER IMMUNOTHERAPY
#214Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies
#215BAT ASSAYS FOR IN VITRO DETERMINATION OF ALLERGIC REACTION
#216Human otic progenitor identification and isolation
#217METHODS AND COMPOSITIONS FOR NON-SMALL CELL LUNG CANCER IMMUNOTHERAPY
#218Antibody targeting CD47 and application thereof
#219PLASMA EXCHANGE REMOVAL OF SPD-L1
#220Biomarkers for Identifying Relapses in Multiple Sclerosis
#221NOVEL ANTI-CD137 ANTIBODIES AND USES THEREOF
#222OX40-TARGETED ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#223PEPTIDE SELECTIVELY BINDING TO CANCER CELL-DERIVED EXOSOME, AND USES THEREOF
#224METHOD FOR DETECTING INFLAMMATION-RELATED PLATELET ACTIVATION
#225METHOD FOR LABELING INTRACELLULAR AND EXTRACELLULAR TARGETS OF LEUKOCYTES
#226CD37-BINDING MOLECULES IMMUNOCONJUGATES THEREOF
#227Multiple Myeloma Mapping and Uses Thereof
#228CD127 EXPRESSION INVERSELY CORRELATES WITH FOXP3 AND SUPPRESSIVE FUNCTION OF CD4+ TREGS
#229Aptamers Specific for TLR-4 and Uses Thereof
#230Method for diagnosis based on circulating extracellular vesicles
#231METHODS AND DEVICES FOR HIGH THROUGHPUT PURIFICATION
#232Adult stem cell compositions and methods of identification and isolation
#233ANTIBODIES AGAINST CDCP1 FOR THE TREATMENT AND DETECTION OF CANCER
#234BIOLOGICAL VESICLES ISOLATION AND DISCOVERY METHODS AND SYSTEMS
#235METHODS OF DIAGNOSING AND TREATING LUPUS
#236ANTI-BST2 ANTIBODIES TARGETING BST2 LONG ISOFORM
#237TARGETING DNA-PKCS AND B7-H1 TO TREAT CANCER
#238IDENTIFICATION OF HEALTH STATUS IN THE ELDERLY USING IMMUNOLOGICAL BIOMARKERS
#239BIOSENSING DEVICE FOR DETECTING CANCER
#240Use of Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies
#241IN VITRO METHOD FOR THE PROGNOSIS OF DISEASE PROGRESSION IN A PATIENT THAT SUFFERS FROM OR IS AT RISK OF DEVELOPING A SOLID TUMOR
#242ANTI-ABCG2 ANTIBODIES AND USES THEREOF
#243Method for Enriching Extracellular Vesicles From Biological Fluid Samples
#244METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#245METHOD OF ISOLATING CIRCULATING TUMOR CELLS
#246Method of Identifying Pro-Inflammatory Dendritic Cells
#247Devices and disposables for patient-specific cell therapy manufacturing
#248Flow Cytometry System and Methods for the Diagnosis of Infectious Disease
#249STRATEGIES TO ASSESS AND/OR PRODUCE CELL POPULATIONS WITH PREDICTIVE ENGRAFTMENT POTENTIAL
#250Methods of isolating a biological entity
#251Method for Determining Prognosis of Cancer
#252C5aR INHIBITOR REDUCTION OF URINARY sCD163
#253MARKER AND PRODUCT FOR AUXILIARY DIAGNOSIS OF VALVULAR HEART DISEASE (VHD)
#254METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER
#255METHODS AND ASSAYS WITH POPULATIONS OF CELLS
#256Detection reagent and therapeutic target for B cell tumor after targeted therapy and related application
#257METHODS FOR PROGNOSING AND PREVENTING METASTATIC LIVER DISEASE
#258CYTOMETRIC ASSAYS
#259KITS AND ASSAYS TO DETECT CIRCULATING MULTIPLE MYELOMA CELLS FROM BLOOD
#260CD8+T-CELL SUBSETS AS MARKERS FOR PREDICTION OF DELAYED FRACTURE HEALING
#261FGFR/PD-1 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#262METHODS AND KITS FOR DIAGNOSING MILD COGNITIVE IMPAIRMENT
#263METHODS FOR INKJET PRINTING OBJECTS FOR MICROFLUIDIC DEVICES
#264ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE
#265ANTI-PSGL-1 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFALMMATORY PHENOTYPES AND USES THEREOF
#266Method of isolating and detecting exosomal biomarkers of glioblastoma malignancy
#267PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY
#268CELL POPULATION COMPRISING MESENCHYMAL STEM CELLS DERIVED FROM FETAL APPENDAGE, METHOD FOR PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION
#269Single use tubing set for making genetically modified donor cells for reinfusion into a patient
#270METHODS FOR DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER
#271METHODS AND AGENTS FOR DETERMINING PATIENT STATUS
#272Method of exosome analysis, reagent for exosome analysis, and analyzer for exosome
#273IMMUNE CELL SIGNATURE FOR BACTERIAL SEPSIS
#274Anti-SIRPa antibodies and their therapeutic applications
#275METHODS OF PREDICTING ENDOMETRIAL RECEPTIVITY
#276SOLUBLE PROGRAMMED CELL DEATH PROTEIN-1 AS A BIOMARKER IN CANCER PATIENTS
#277IMMUNITY MECHANISM AND THERAPEUTIC DRUG FOR GASTROINTESTINAL DISEASES
#278ARTIFICIAL INTELLIGENCE FOR EARLY CANCER DETECTION
#279APTAMER SPECIFICALLY BINDING TO CANCER STEM CELLS, AND USE THEREOF
#280BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#281Equipment and procedure for culturing, separating, and genetically modifying donor cells for reinfusion into a patient
#282Early diagnosis of infections
#283METHODS OF TREATING INFECTIONS BY BLOCKING PATHOGEN MIMICS OF CD47
#284USE OF CD9 AS A BIOMARKER AND AS A BIOTARGET IN GLOMERULONEPHRITIS OR GLOMERULOSCLEROSIS
#285BROWN ADIPOCYTE PROGENITORS IN HUMAN SKELETAL MUSCLE
#286THERAPEUTICALLY ACTIVE CELLS AND EXOSOMES
#287Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer
#288COLORECTAL CANCER SCREENING EXAMINATION AND EARLY DETECTION METHOD
#289Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#290MULTIMERS FOR REDUCING THE INTERFERENCE OF DRUGS THAT BIND CD47 IN SEROLOGICAL ASSAYS
#291ANTI-CD371 ANTIBODIES AND USES THEREOF
#292COMPOSITIONS AND METHODS FOR DETECTION OF DISEASE-RELATED ANTIBODY
#293METHOD OF DETECTING TIM-3 USING ANTIBODY MOLECULES TO TIM-3
#294PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#295Glycated CD59 peptides, their preparation, and uses thereof
#296SELECTION OF T CELL RECEPTORS
#297Biomarkers for CNS Disease Modification
#298Anti-PD-L1 antibodies and variants
#299METHOD FOR ESTIMATING THE EFFECTIVENESS OF TREATMENT WITH AN ANTI-CD20 AGENT IN A PATIENT WITH RHEUMATOID ARTHRITIS AND HAVING HAD AN INADEQUATE RESPONSE TO AT LEAST ONE BIOTHERAPY
#300EXOSOME ASSAY FOR DEPRESSION AND PSYCHOSIS AND METHODS AND AGENTS FOR TREATING DEPRESSION, PSYCHOSIS AND SCHIZOPHRENIA